Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
| Autore principale: | |
|---|---|
| Altri autori: | |
| Natura: | Tesi |
| Lingua: | English |
| Pubblicazione: |
Brac University
2023
|
| Soggetti: | |
| Accesso online: | http://hdl.handle.net/10361/18736 |